Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes

    ... Overall Response (complete or partial remission, red blood cell [RBC] or platelet transfusion independence [TI], or ...

    Research Article last updated 12/09/2015 - 8:56am.

  2. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

    ... to Medicare claims. Baseline characteristics, treatment ( red blood cell transfusions, hematopoietic growth factors, hypomethylating ...

    Research Article last updated 11/19/2012 - 2:37pm.

  3. The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline.

    ... expected with the aging population. Treatment includes red blood cell transfusion for anemia . The immunomodulatory agents ...

    Research Article last updated 10/01/2012 - 10:04am.

  4. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes

    ... risks associated with transfusions, chronic anemia and red blood cell (RBC) transfusion dependence impact negatively on survival and ...

    Research Article last updated 06/15/2012 - 2:03pm.

  5. Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes.

    ... 24 and 52 weeks of therapy despite ongoing receipt of red blood cell transfusions. Bone Marrow ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Myelodysplastic syndromes and the role of iron overload.

    ... in patients with MDS due to the long-term use of red blood cell transfusions in patients with symptomatic anemia . ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Durable long-term responses in patients with myelodysplastic syndromes treated with lenalidomide.

    ... Five of these patients had an ongoing requirement for red blood cell transfusions despite previous treatment with recombinant ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Blood Transfusions

    Blood Transfusions A transfusion usually involves only certain parts of blood. These might be the red blood cells, platelets or plasma . Rarely is whole blood (red cells, ... clinics, or even the patient’s home. Red blood cell transfusions can take up to four hours. Transfusions of other blood ...

    Topic section last updated 03/29/2016 - 7:17pm.

  9. Rasha Iqbal's Transplant Experience Amplifies Her Desire for Research Career

    ... mosquito bite. While scratching the bite, I discovered red spots on my skin called petechiae . They started appearing all over my hands and feet. After a trip to the doctor, a blood test, and a bone marrow biopsy , my doctor confirmed her ...

    Patient Chronicle last updated 11/13/2015 - 11:27am.

  10. Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes

    ... catheter placement (ORadj=6.47, 95% CI: 2.37, 17.62) and red blood cell transfusion (ORadj=4.60, 95% CI: 2.29, 9.23) were associated ...

    Research Article last updated 12/05/2011 - 10:09am.